Anonymize earnings release drafts for pre-announcement review – CCPA/HIPAA-compliant de-identification per 17 CFR §243.100
Earnings releases furnished as 8-K exhibits contain forward-looking statements and non-GAAP metrics that, in draft form, constitute material non-public information subject to Reg FD at 17 CFR §243.100. These drafts identify named executives providing quotes and may reference named customers or partners. anonym.legal pseudonymizes those identifiers so draft earnings releases can circulate for pre-announcement review without triggering Reg FD concerns.
When this applies
Apply this workflow when draft earnings releases, earnings call scripts, or investor-day presentation materials are circulated to investor-relations advisers, public-relations firms, or external reviewers before the public announcement date where the specific named individuals are not required by the reviewer.
How anonym.legal handles it
- Upload draft earnings releases, earnings call scripts, or investor-day presentations in PDF or DOCX format.
- The engine identifies named executives quoted in the release, named customers or partners referenced in business-performance commentary, and any individual identified in supplemental data packages.
- Each named individual and entity is pseudonymized consistently across the press release body, supplemental financial tables, and call script.
- Revenue figures, non-GAAP metrics, guidance ranges, and operational statistics are retained as structural content for review.
- Reg FD §243.100 citation references in counsel review memoranda are preserved verbatim.
- The reversible mapping is stored encrypted for re-identification before the earnings release is issued publicly.
- The pseudonymized draft is exported for pre-announcement review by advisers.
What you provide
- Draft earnings release and supplemental financial data package in PDF or DOCX format
- Earnings call script or prepared remarks in DOCX format
- Scope instruction identifying named executives and any named third parties to pseudonymize
Limitations & cautions
- anonym.legal does not assess whether the earnings release satisfies Regulation G requirements for non-GAAP financial measures or whether the simultaneous-disclosure obligation of Reg FD §243.100 has been satisfied; those determinations require securities counsel.
- Pseudonymizing named executive quotes in an earnings release draft is a review tool; the final issued release must contain the actual executive's name as attributed.
- Forward-looking statements containing projections unique to a specific company's business may retain indirect company-level identifiability that does not implicate personal data.
- The tool does not furnish the 8-K exhibit or press release to the SEC or any wire service.
FAQ
Can this workflow pseudonymize CEO and CFO quotes in the press release body?
Yes. Named executive quotes are pseudonymized at the individual level while the substantive content of the quoted remarks — financial commentary, strategic rationale, guidance discussion — is preserved for review.
Will non-GAAP reconciliation tables be preserved after pseudonymization?
Yes. Non-GAAP reconciliation schedules and supplemental financial tables are non-personal structural content and are preserved in plain text; only named individual references are pseudonymized.
Is this workflow relevant for quiet-period communications to investor-relations firms?
Yes. Pre-announcement drafts circulated to investor-relations agencies during a quiet period involve material non-public information. Pseudonymizing the specific named parties in the draft limits the scope of individually identified MNPI circulated to external parties.